|
ACA Title/ Section
|
Name
|
Purpose
|
| III/3022 |
Accountable Care Organizations |
New vertically-integrated provider organizations to assume the risk for patient outcomes and health |
| II/2703 |
Patient-Centered Medical Homes |
Coordinated primary care for low-income and chronically ill |
| III/3025 |
Hospital Readmissions |
Penalties on hospitals with high rates of readmissions within 30 days of discharge |
| III/3008 |
Hospital-Acquired Infections |
Penalties on hospitals with high rates of healthcare associated infections |
| VI/6301-2 |
Patient-Centered Outcomes Research Institute |
New institute to commission research on comparative effectiveness of therapies and treatments |
| III/3002 |
Physician Quality Reporting |
Physicians must report quality data or face financial penalties |
| I/3403 |
Administrative Simplification |
Reducing paperwork and administrative burdens |
| VII |
Biosimilar Drugs |
Allowing manufacturing, marketing and sale of biopharmaceutical similar drugs |
| III/3001 |
Hospital Value-Based Purchasing Program |
Payments to hospitals will be tied to performance on quality measures |
| III/3011 |
National Quality Strategy |
Coordinated and annually updated strategy on national healthcare quality improvement |
| IV/4001 |
National Prevention Strategy |
National coordinated strategy to emphasize health promotion and disease prevention |
| V/5011 |
National Workforce Commission |
National data collection and analysis and policy recommendations to improve the quantity and quality of the workforce |
